Detection of potential tumor-initiating cells (TICs) in peripheral blood to anticipate the relapse in breast and colorectal cancer
AllerTrap is a portable and autonomous device to collect airborne particles in motion. Over 500 million people worldwide suffer allergy symptoms because of the exposure to pollen and fungal spores present in the atmosphere.
CONCLUSIVE Clinical Test in patients with Epilepsy. Exclusive Technology in combination with a high qualified group at the Cognitive and Computational Neuroscience Laboratory at the Center for Biomedical Technology
Platform for adoption of a healthy lifestyle: nutrition, physical activity, notifications, evolution and health monitoring
e-Glance is a virtual reality App that allows blind people to explore unknown indoors, which are created from the real world, just they need their smartphone.
New paradigm in the fight against cancer and relapse of patients already treated: elimination of tumor initiator cells
Enabling the nanomaterial-solutions journey from the lab to the industry by means of an automated process
Platform that integrates different games that allow rehabilitation of facial muscles in children with Infantile Cerebral Palsy (ICP)
Augmentative and alternative communication solution for people with cognitive disabilities and / or older people based on the use of mobile technology and NFC pictographic cards
VADET offers an innovative solution for diagnosing attentional deficits, by integrating an eye-tracking device with a software, which has been specifically designed for that purpose by neuropsychologists.
A new method to automatically detect, segment and measure the heart ventricles in Computed Tomography Pulmonary Angiographies
Non-Invasive and fast test based on a visual test and a measurement system for assistance to medical staff in diagnosis of neurological disorders
Shoulder robotics exoeskeleton for evaluation of injury, recovery and rehabilitation. This solution, besides attending rehabilitation, is an assesment tool on the evolution of the lesion and can be easily tuned for each patient without excessive training of the physiotherapist.
Detectallergen supposes a new component resolved-diagnosis, with low cost and high efficiency. This method increases the efficiency of diagnosis (20-40%) that implies an improvement in the treatment and the quaility of life of patients. Over 150 million people in Europe suffer from some type of allergy.
SFS is a versatile and inexpensive production method for fibroin-based biomaterials to produce fibers that combine biocompatibility and high performance.